Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS.

about

Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases The Interdisciplinary Management of Brain Metastases

P2860

Q36533041-6285EBD5-AB38-40B7-ADC9-83998726F842 Q37081263-8DF593FE-EBE2-49D7-96DE-4181292C5F27

P2860

Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS.

Item

http://www.wikidata.org/entity/Q38101607

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Revisiting the role of systemi ...... etastatic melanoma to the CNS.

@en

type

Item

label

Revisiting the role of systemi ...... etastatic melanoma to the CNS.

@en

prefLabel

Revisiting the role of systemi ...... etastatic melanoma to the CNS.

@en

P1476

Revisiting the role of systemi ...... etastatic melanoma to the CNS.

@en

P2093

Adam Januszewski

http://www.w3.org/2001/XMLSchema#string

Angus Dalgleish

http://www.w3.org/2001/XMLSchema#string

Dionysis Papadatos-Pastos

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

P304

559-567

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERA.13.33

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23617347

http://www.w3.org/2001/XMLSchema#string

Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS.

about

P2860

P2860

Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698